Vital Therapies enrolls first subject in VTL-308
Vital Therapies announced the first subject was recently enrolled in its phase 3 trial designated VTL-308. There are now ten sites open for enrollment in VTL-308. The Company expects to enroll subjects among roughly 40 sites in the US and EU. May 23, 2016